Combinatorial Delivery of Docetaxel- and Erlotinib-Loaded Functionalized Nanostructured Lipid Carriers for the Treatment of Triple-Negative Breast Cancer Using Quality-by-Design Approach

• Main Authors: Aiswarya Chaudhuri (Author), Dulla Naveen Kumar (Author), Saurabh Kumar Srivastava (Author), Dinesh Kumar (Author), Umesh Kumar Patil (Author), Avanish Singh Parmar (Author), Sanjay Singh (Author), Ashish Kumar Agrawal (Author)
• Format: Book
• Published: MDPI AG, 2024-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

This study explored the combined administration of docetaxel (DOC) and erlotinib (ERL) using nanostructured lipid carriers (NLCs), with folic acid (FA) conjugation to enhance their synergistic anticancer efficacy against triple-negative breast cancer. NLCs were developed through hot melt homogenizat...